Baillie Gifford & CO Rx Sight, Inc. Transaction History
Baillie Gifford & CO
- $131 Billion
- Q3 2024
A detailed history of Baillie Gifford & CO transactions in Rx Sight, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 419,004 shares of RXST stock, worth $14 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
419,004
Previous 358,215
16.97%
Holding current value
$14 Million
Previous $21.6 Million
3.91%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding RXST
# of Institutions
224Shares Held
32.3MCall Options Held
394KPut Options Held
32K-
Ra Capital Management, L.P. Boston, MA3.92MShares$131 Million2.7% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$80.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.29MShares$76.5 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC1.75MShares$58.4 Million0.01% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.17MShares$39.1 Million0.09% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $924M
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...